Skip to main content

S&P 500 —

Nasdaq-100 —

Dow —

Nasdaq · Common stock

Pharvaris (PHVS)

$31.54 +$0.13 (+0.41%)

Day’s range
$31.30–$32.08
Volume
347,291

PHVS price history

PHVS closed at $31.54 on Oct. 26, 2026. Over the past year, its daily close ranged from $21.59 on Nov. 7, 2025 to $38.86 on Sept. 14, 2026.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $20 to $40, not from zero.
Data table: PHVS daily closes, the past year
PHVS daily closing prices, Oct. 27, 2025 to Oct. 26, 2026, newest first
DateClose
Oct. 26, 2026$31.54
Oct. 23, 2026$31.41
Oct. 22, 2026$30.68
Oct. 21, 2026$30.66
Oct. 20, 2026$30.90
Oct. 19, 2026$29.77
Oct. 16, 2026$27.74
Oct. 15, 2026$29.64
Oct. 14, 2026$30.02
Oct. 13, 2026$30.02
Oct. 12, 2026$30.89
Oct. 9, 2026$31.10
Oct. 8, 2026$31.12
Oct. 7, 2026$31.68
Oct. 6, 2026$31.12
Oct. 5, 2026$30.49
Oct. 2, 2026$31.19
Oct. 1, 2026$31.01
Sept. 30, 2026$31.72
Sept. 29, 2026$31.73
Sept. 28, 2026$31.91
Sept. 25, 2026$32.02
Sept. 24, 2026$32.99
Sept. 23, 2026$33.07
Sept. 22, 2026$35.20
Sept. 21, 2026$36.02
Sept. 18, 2026$36.37
Sept. 17, 2026$38.00
Sept. 16, 2026$37.55
Sept. 15, 2026$38.06
Sept. 14, 2026$38.86
Sept. 11, 2026$38.02
Sept. 10, 2026$37.51
Sept. 9, 2026$37.74
Sept. 8, 2026$37.84
Sept. 4, 2026$35.25
Sept. 3, 2026$35.66
Sept. 2, 2026$35.17
Sept. 1, 2026$34.93
Aug. 31, 2026$34.61
Aug. 28, 2026$35.32
Aug. 27, 2026$37.00
Aug. 26, 2026$37.00
Aug. 25, 2026$37.23
Aug. 24, 2026$37.31
Aug. 21, 2026$36.27
Aug. 20, 2026$36.39
Aug. 19, 2026$36.27
Aug. 18, 2026$36.10
Aug. 17, 2026$35.32
Aug. 14, 2026$35.14
Aug. 13, 2026$34.04
Aug. 12, 2026$36.46
Aug. 11, 2026$34.42
Aug. 10, 2026$34.84
Aug. 7, 2026$34.91
Aug. 6, 2026$34.45
Aug. 5, 2026$33.42
Aug. 4, 2026$33.87
Aug. 3, 2026$32.25
July 31, 2026$32.62
July 30, 2026$33.88
July 29, 2026$32.62
July 28, 2026$33.65
July 27, 2026$33.97
July 24, 2026$34.17
July 23, 2026$33.26
July 22, 2026$34.36
July 21, 2026$34.45
July 20, 2026$33.55
July 17, 2026$34.94
July 16, 2026$33.66
July 15, 2026$35.16
July 14, 2026$34.42
July 13, 2026$35.07
July 10, 2026$35.07
July 9, 2026$35.96
July 8, 2026$35.92
July 7, 2026$34.59
July 6, 2026$33.22
July 2, 2026$33.86
July 1, 2026$33.95
June 30, 2026$34.58
June 29, 2026$34.71
June 26, 2026$34.01
June 25, 2026$33.30
June 24, 2026$33.29
June 23, 2026$33.19
June 22, 2026$33.00
June 18, 2026$32.80
June 17, 2026$33.41
June 16, 2026$31.46
June 15, 2026$31.54
June 12, 2026$30.72
June 11, 2026$32.20
June 10, 2026$31.51
June 9, 2026$31.60
June 8, 2026$31.59
June 5, 2026$31.09
June 4, 2026$31.63
June 3, 2026$30.14
June 2, 2026$28.98
June 1, 2026$29.10
May 29, 2026$30.16
May 28, 2026$29.86
May 27, 2026$29.47
May 26, 2026$29.88
May 22, 2026$29.68
May 21, 2026$30.54
May 20, 2026$29.45
May 19, 2026$28.95
May 18, 2026$28.81
May 15, 2026$30.40
May 14, 2026$30.70
May 13, 2026$32.94
May 12, 2026$31.25
May 11, 2026$29.95
May 8, 2026$30.09
May 7, 2026$29.68
May 6, 2026$30.11
May 5, 2026$30.02
May 4, 2026$30.02
May 1, 2026$29.44
April 30, 2026$31.01
April 29, 2026$29.83
April 28, 2026$28.22
April 27, 2026$28.71
April 24, 2026$28.63
April 23, 2026$27.29
April 22, 2026$30.04
April 21, 2026$29.15
April 20, 2026$28.97
April 17, 2026$28.58
April 16, 2026$28.78
April 15, 2026$29.14
April 14, 2026$28.68
April 13, 2026$27.88
April 10, 2026$26.63
April 9, 2026$27.07
April 8, 2026$27.56
April 7, 2026$27.84
April 6, 2026$28.37
April 2, 2026$28.56
April 1, 2026$29.45
March 31, 2026$28.25
March 30, 2026$27.29
March 27, 2026$27.35
March 26, 2026$27.39
March 25, 2026$26.15
March 24, 2026$25.34
March 23, 2026$25.70
March 20, 2026$26.00
March 19, 2026$26.13
March 18, 2026$26.17
March 17, 2026$26.92
March 16, 2026$26.93
March 13, 2026$25.42
March 12, 2026$26.38
March 11, 2026$27.43
March 10, 2026$25.89
March 9, 2026$26.51
March 6, 2026$25.91
March 5, 2026$25.84
March 4, 2026$26.80
March 3, 2026$26.78
March 2, 2026$28.00
Feb. 27, 2026$28.39
Feb. 26, 2026$28.00
Feb. 25, 2026$27.63
Feb. 24, 2026$27.95
Feb. 23, 2026$27.66
Feb. 20, 2026$28.10
Feb. 19, 2026$28.00
Feb. 18, 2026$27.01
Feb. 17, 2026$26.61
Feb. 13, 2026$26.45
Feb. 12, 2026$26.60
Feb. 11, 2026$27.31
Feb. 10, 2026$27.48
Feb. 9, 2026$27.01
Feb. 6, 2026$26.42
Feb. 5, 2026$25.14
Feb. 4, 2026$26.54
Feb. 3, 2026$27.81
Feb. 2, 2026$27.43
Jan. 30, 2026$27.05
Jan. 29, 2026$27.79
Jan. 28, 2026$27.86
Jan. 27, 2026$27.19
Jan. 26, 2026$27.59
Jan. 23, 2026$27.98
Jan. 22, 2026$27.98
Jan. 21, 2026$27.51
Jan. 20, 2026$26.21
Jan. 16, 2026$25.09
Jan. 15, 2026$25.65
Jan. 14, 2026$25.63
Jan. 13, 2026$26.00
Jan. 12, 2026$26.10
Jan. 9, 2026$25.89
Jan. 8, 2026$25.00
Jan. 7, 2026$25.04
Jan. 6, 2026$24.05
Jan. 5, 2026$24.88
Jan. 2, 2026$26.48
Dec. 31, 2025$27.75
Dec. 30, 2025$26.25
Dec. 29, 2025$25.74
Dec. 26, 2025$25.76
Dec. 24, 2025$25.93
Dec. 23, 2025$25.85
Dec. 22, 2025$27.07
Dec. 19, 2025$25.59
Dec. 18, 2025$24.02
Dec. 17, 2025$24.09
Dec. 16, 2025$24.72
Dec. 15, 2025$23.90
Dec. 12, 2025$24.16
Dec. 11, 2025$23.98
Dec. 10, 2025$23.68
Dec. 9, 2025$24.04
Dec. 8, 2025$25.35
Dec. 5, 2025$26.42
Dec. 4, 2025$27.69
Dec. 3, 2025$29.37
Dec. 2, 2025$24.12
Dec. 1, 2025$26.00
Nov. 28, 2025$28.38
Nov. 26, 2025$27.72
Nov. 25, 2025$25.45
Nov. 24, 2025$25.39
Nov. 21, 2025$24.83
Nov. 20, 2025$24.20
Nov. 19, 2025$24.54
Nov. 18, 2025$23.97
Nov. 17, 2025$24.92
Nov. 14, 2025$23.55
Nov. 13, 2025$24.26
Nov. 12, 2025$25.81
Nov. 11, 2025$24.12
Nov. 10, 2025$22.63
Nov. 7, 2025$21.59
Nov. 6, 2025$21.80
Nov. 5, 2025$21.72
Nov. 4, 2025$21.64
Nov. 3, 2025$22.50
Oct. 31, 2025$22.22
Oct. 30, 2025$22.24
Oct. 29, 2025$22.08
Oct. 28, 2025$22.65
Oct. 27, 2025$22.82

Key figures

52-week range
$21.59–$38.86Low Nov. 7, 2025; high Sept. 14, 2026
Average daily volume
789,820Past 3 months
Market value
$2.06B
Dividend yield
—
From 52-week high
−18.84%

Price change

1 month
−1.50%
3 months
−7.70%
Year to date
+13.66%
1 year
+37.19%

$1,000 a year ago

$1,000 put into PHVS at the close on Oct. 24, 2025 would be worth $1,372.

Price only, dividends not included.

What Wall Street says about PHVS

In the past 90 days, Wall Street firms published 13 rating or price-target actions on PHVS: 1 upgrade, 2 reiterated ratings and 10 raised price targets.

Rating and price-target actions on PHVS, past 90 days
ActionRating
B of A SecuritiesUpgradeNeutral to Buy$44
GuggenheimRaises targetBuy$40 to $44
CitizensRaises targetMarket outperform$75 to $79
Leerink PartnersRaises targetOutperform$50 to $65
Morgan StanleyRaises targetOverweight$46 to $62
RBC CapitalRaises targetOutperform$52 to $62
WedbushRaises targetOutperform$42 to $50
Wells FargoRaises targetOverweight$55 to $65
HC Wainwright & Co.ReiteratesBuy$60
WedbushReiteratesOutperform$42
CitizensRaises targetMarket outperform$74 to $75
GuggenheimRaises targetBuy$39 to $40
RBC CapitalRaises targetOutperform$51 to $52

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About Pharvaris N.V. Ordinary Shares

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks. The company is also running open-label extension studies in both on-demand (RAPIDe-2) and prophylactic (CHAPTER-4) settings to collect long-term safety and efficacy data in HAE patients.

Employees
129
Listed
Feb. 5, 2021

pharvaris.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about PHVS is on the site yet.